Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT06328595
  4. Details
NCT06328595 Clinical Trial

Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria

COVID-19 Clinical Trial

Official title:
A Cross-Sectional Analysis of Muscular and Joint Symptoms in COVID-19 Patients: Insights From Syria

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06328595
Other study ID # Cross sectional
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 22, 2022
Est. completion date August 20, 2023

Study information
Verified date March 2024
Source Syrian Private University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Observation study, shows the relation between musckeloskeletal symptoms with during and post Covid-19 infection, by asking participants questions about there age,job,which vaccination covid participants took, residual area, social status, number of time of covid-19 infection, number of joint affected and duration of joint pain and asking if there any malaise or fatigue

Recruitment information / eligibility
Status Completed
Enrollment 1039
Est. completion date August 20, 2023
Est. primary completion date May 4, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 78 Years
Eligibility Inclusion Criteria: - Participants aged = 18 years with a prior COVID-19 infection or suspicious COVID-19 infection and currently residing in Damascus. Exclusion Criteria: - Participants below 18 years, those unwilling to give consent, individuals with joint surgery history, pregnant women, or those who had taken immunosuppressive drugs before the study.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Syrian Arab Republic Mohamad Zaid Ahmad Abdalla Damascus

Sponsors (1)
Lead Sponsor Collaborator
Syrian Private University

Country where clinical trial is conducted

Syrian Arab Republic, 

Outcome
Type Measure Description Time frame Safety issue
Primary The Demographic characteristics were classified into four groups: Gender, Residual area, education level. Gender was either male or female. Residual area was divided into tow categories: Rural or City. Social status were divided into four types: Single, Married, Divorced, Widow . The study took 6 months to finish it with hard work, it was hard to reach our participants so we didn't only collect our data from google form we also colleted our data from Al-Mouassa University Hospital outpatients clinics and Damascus University
See also
  Status Clinical Trial Phase
Recruiting NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Active, not recruiting NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure